Vanguard Group Inc Fennec Pharmaceuticals Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,013,626 shares of FENC stock, worth $6.19 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,013,626
Previous 1,140,063
11.09%
Holding current value
$6.19 Million
Previous $12.8 Million
11.88%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding FENC
# of Institutions
69Shares Held
14.4MCall Options Held
53.2KPut Options Held
83.9K-
Southpoint Capital Advisors LP New York, NY4.08MShares$24.9 Million1.02% of portfolio
-
Sonic Gp LLC Honolulu, HI2.41MShares$14.7 Million35.34% of portfolio
-
Dg Capital Management, LLC New York, NY1.51MShares$9.24 Million10.39% of portfolio
-
Solas Capital Management, LLC Darien, CT1.11MShares$6.78 Million8.43% of portfolio
-
Black Rock Inc. New York, NY927KShares$5.67 Million0.0% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $159M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...